Does Weed Raise Blood Pressure? What Science Says

Cannabis acutely raises blood pressure in most people, particularly systolic pressure, and speeds up the heart. But the long-term relationship between regular marijuana use and lasting hypertension is far less clear, with several large studies finding no independent link. The disconnect between what happens in the hour after a hit and what shows up on a blood pressure reading years later makes this a genuinely complicated question, not one that lends itself to a tidy yes or no.

What Happens in the First Hour

Within minutes of inhaling THC, your heart rate climbs and your blood pressure rises. A controlled study published in the Journal of the American Heart Association measured these changes precisely: inhaled THC raised mean arterial pressure by about 5 to 7 mmHg and increased heart rate by roughly 16 to 17 beats per minute compared to placebo. Notably, inhaled CBD alone did not produce either effect, suggesting that the blood pressure spike is driven by THC specifically, not cannabis in general.¹ This acute rise appears to come from activation of the sympathetic nervous system, the same “fight or flight” wiring that speeds up your heart during stress or exercise.²

The combination of faster heart rate and higher blood pressure increases the heart’s demand for oxygen. For a healthy young person, this is usually inconsequential. But the cardiovascular system is doing extra work during that window, and for people whose hearts are already under strain, the timing matters.

The Dizzy Drop When You Stand Up

Here is where the picture gets counterintuitive. The same drug that initially pushes blood pressure up can also cause a sharp drop when you stand, a phenomenon called orthostatic hypotension. THC slightly increases blood pressure while you are sitting or lying down, but on occasion produces a marked fall in pressure upon standing.³ This is the lightheadedness or “green out” feeling that some users experience.

Research using brain blood flow measurements found that about 28% of participants reported severe dizziness after THC, and those individuals showed the most pronounced drops in both blood pressure and cerebral blood flow when standing.⁴ An earlier study confirmed that subjects who experienced severe dizziness showed marked blood pressure decreases and reduced cerebral blood velocity during upright posture, suggesting the fainting risk comes from both low blood pressure and impaired ability of the brain’s blood vessels to compensate.⁵

So in the same session, cannabis can push blood pressure up while you are seated and then pull it down sharply when you stand. The severity of the standing drop does not appear to track with how much THC is in your blood, which makes it hard to predict who will be affected and when.

Does Long-Term Use Cause Lasting Hypertension?

This is the question most people really want answered, and the evidence is surprisingly reassuring, at least by the measures available so far. Several large population studies have tried to link regular cannabis use to a diagnosis of hypertension over time, and most come up empty.

The strongest evidence comes from the CARDIA study, which followed a cohort of Black and white young adults for 35 years. It found no association between cumulative lifetime cannabis use and the risk of developing hypertension. The result held up across subgroups divided by sex, race, alcohol use, and tobacco smoking.⁶ A separate analysis of middle-aged adults from the MESA study found essentially the same thing: a history of regular cannabis smoking was not associated with higher systolic or diastolic blood pressure, nor with a greater prevalence of hypertension.⁷

National survey data from NHANES tell a similar story. An analysis of nearly 10,000 middle-aged adults over a decade found that a history of monthly cannabis use for more than a year was not independently associated with increased blood pressure or prevalent hypertension.⁸ An earlier NHANES analysis did find that recent cannabis use was tied to a small uptick in systolic pressure, about 1.4 mmHg, but there was no association with an actual hypertension diagnosis.⁹

A 1.4 mmHg difference is real but tiny in clinical terms. For context, a single salty meal can swing your systolic pressure by more than that. The fact that this small bump does not translate into higher rates of hypertension diagnosis across multiple large datasets suggests it is not a major driver of chronic cardiovascular disease on its own.

The Exception for Heavy Users

Where the data do show a signal is at the heavy end of use. A separate NHANES analysis covering 2005 to 2014 found that heavy current users had about 1.8 times the odds of elevated blood pressure compared to people who had never used cannabis. Lighter or past use showed no such difference.¹⁰ “Heavy” in this context meant frequent use in the past 30 days. The researchers noted that the overall higher prevalence of elevated blood pressure among current users was driven almost entirely by this heavy-use subgroup.

Interestingly, a large French study found that heavy cannabis use was associated with lower blood pressure levels in both men and women, though the effect was more pronounced in women.¹¹ This conflicting finding highlights a frustrating reality in the field: the relationship between cannabis and blood pressure is probably shaped by factors that are hard to isolate in observational studies, including diet, stress levels, concurrent substance use, and genetics.

Sex Differences in Blood Pressure Response

Men and women appear to respond differently. In a study of cannabis consumers enrolled in the Herbal Heart Study, male participants had a higher median systolic blood pressure than females, and abnormal blood pressure was identified in half of male consumers versus about 11% of female consumers. Among heavy users specifically, the gap persisted: roughly 52% of heavy-using males had abnormal blood pressure compared to about 15% of heavy-using females.¹²

This is consistent with the French study’s observation that the blood-pressure-lowering effect of heavy cannabis use was stronger in women. Whether this sex difference reflects hormonal factors, differences in endocannabinoid signaling, or simply baseline cardiovascular differences between men and women is not yet established. But it does suggest that generalizing about cannabis and blood pressure without considering sex may miss important variation.

Vascular Damage That Blood Pressure Numbers Alone Miss

Even if cannabis does not clearly cause chronic hypertension, the blood vessels themselves may not escape unharmed. A 2025 study in JAMA Cardiology measured endothelial function, the ability of arteries to relax and expand properly, in chronic cannabis smokers, THC-edible users, and non-users. Both smoking and edible groups showed significantly impaired arterial function compared to non-users. The degree of impairment was comparable to what is seen in tobacco smokers.¹³

The mechanisms differed between the groups. Cannabis smokers showed reduced nitric oxide production in their blood vessel cells, which points to combustion byproducts damaging the endothelium much the way tobacco smoke does. THC-edible users showed the same degree of arterial stiffness but without the nitric oxide deficit, suggesting THC itself may impair vascular function through a separate pathway that does not depend on inhaling smoke. This is a finding worth paying attention to, because it means switching from smoking to edibles may not eliminate cardiovascular risk, even though it does avoid most respiratory harm.

Tolerance and the Withdrawal Rebound

Regular users often report that the acute effects, the racing heart, the blood pressure bump, fade over time. Clinical evidence supports this: tolerance to the cardiovascular effects of THC develops within days to a few weeks of regular use.¹⁴ This may partly explain why chronic users do not show higher resting blood pressure in population surveys. Their cardiovascular system has adjusted to the presence of THC.

But when daily users suddenly stop, blood pressure can jump. A controlled study found that systolic blood pressure rose from an average of about 130 mmHg during active cannabis use to about 140 mmHg during abstinence, and diastolic pressure climbed from roughly 75 to about 82 mmHg.¹⁵ A jump of 10 mmHg systolic puts some people into a range that cardiologists would flag. This rebound effect is not widely discussed but matters for anyone who uses cannabis daily and is planning to quit or take a tolerance break. Gradual tapering, rather than cold-turkey cessation, may be worth discussing with a doctor, especially if blood pressure is already borderline.

How You Consume It Matters

A systematic review examining cardiovascular and respiratory effects by route of administration found that tachycardia, an elevated heart rate, was the most common cardiovascular effect across all routes, whether smoking, vaping, eating, or dabbing.¹⁶ Smoking carried the broadest risk profile, with associations ranging from arrhythmias to heart attack. Edibles largely spared the lungs but still triggered the heart-rate increase.

The JAMA Cardiology study described above adds nuance: even though edibles avoid combustion toxins, they still impaired arterial function. So the cardiovascular trade-offs of different consumption methods are not as simple as “edibles are safe, smoking is not.” The heart-rate spike and the endothelial effects appear to be at least partly about THC itself, regardless of how it enters the body.

The Underlying Plumbing

Your body already has its own cannabis-like signaling system. Endocannabinoids, compounds your body makes naturally, play a role in regulating blood pressure, heart rate, and blood vessel tone. Research shows these compounds exert powerful effects on the heart and blood vessels through multiple overlapping pathways, including direct relaxation of blood vessel walls and modulation of the nervous system.¹⁷ Animal studies have also linked endocannabinoids like anandamide to effects on atherosclerotic plaque development, heart rate, and metabolic factors like cholesterol and obesity.¹⁸

When you introduce a flood of external THC, you are essentially hijacking a system that was designed for subtle, localized signaling. That mismatch helps explain why the acute effects are so pronounced and also why the body can adapt with tolerance. The endocannabinoid system’s involvement in blood pressure regulation is one reason some researchers have explored whether cannabinoids could eventually be used therapeutically for hypertension, though that remains a long way from clinical reality.

People with Existing Heart Disease

For people who already have cardiovascular disease, the acute effects of cannabis carry more weight. Even a modest rise in heart rate and blood pressure increases the heart muscle’s demand for oxygen. In patients with coronary artery disease, cannabis smoking reduced the amount of exercise they could do before experiencing chest pain.² The acute sympathetic activation that a healthy heart shrugs off may push a compromised heart closer to its limits.

A small study of older adults using medicinal cannabis for various conditions did find that cannabis treatment improved the proportion of patients whose blood pressure dipped normally during sleep, going from about 27% before treatment to about 46% afterward.¹⁹ Healthy nighttime blood pressure dipping is generally a good prognostic sign. But this was a small observational study, not the kind of evidence that changes clinical recommendations. The overall picture for people with existing heart conditions remains cautious: the acute cardiovascular stress is real, even if the chronic hypertension risk is uncertain.

Synthetic Cannabinoids Are a Different Beast

Products sold as “Spice,” “K2,” or “bonzai” are synthetic cannabinoids that bind to the same receptors as THC but often with far greater potency and far less predictability. Their cardiovascular effects can be extreme. In one case report, an 18-year-old synthetic cannabinoid user developed severe bradycardia followed by a dangerous spike in blood pressure that required emergency intervention.²⁰

Animal studies confirm that synthetic cannabinoids elevate blood pressure, and the mechanism appears to involve the autonomic nervous system rather than the cannabinoid receptors alone. When researchers blocked the ganglionic pathway or alpha-1 adrenergic receptors in rats, the blood pressure increases from synthetic cannabinoids were prevented, but blocking the cannabinoid receptor itself did not help.²¹ In practical terms, the cardiovascular risks of synthetic cannabinoids are qualitatively different from those of plant-derived cannabis, and any blood pressure concerns about natural cannabis should be multiplied several-fold when considering synthetic alternatives.

Where the Research Still Falls Short

Most of what we know about cannabis and blood pressure comes from observational data, cross-sectional surveys, and small controlled studies. There are very few long-term randomized trials, for obvious legal and ethical reasons. The CARDIA study’s 35-year follow-up is impressive, but it relied on self-reported cannabis use, which is notoriously unreliable. People underreport, overreport, and have trouble estimating frequency over decades.

Another gap is the lack of dose-standardized research. “Cannabis use” in a survey could mean a puff of low-THC flower once a month or daily consumption of high-potency concentrates. Today’s commercial cannabis products deliver far more THC per dose than what study participants were using in the 1990s or early 2000s, so older research may underestimate the acute cardiovascular load. Until studies systematically compare standardized doses across different product types, the long-term cardiovascular picture will remain blurry. For now, the honest summary is that cannabis reliably raises blood pressure in the short term, the chronic risk of hypertension appears modest at typical use levels, and the vascular damage from both smoking and THC itself deserves more attention than it currently gets.